東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Practical pharmacology for Alzheimer...

Kudo, Takashi.

FindBook

Google Book

Amazon

博客來

Practical pharmacology for Alzheimer's disease

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Practical pharmacology for Alzheimer's disease/ by Takashi Kudo ... [et al.].
其他作者:	Kudo, Takashi.
出版者:	Cham :Springer International Publishing : : 2016.,
面頁冊數:	viii, 141 p. :ill., digital ;24 cm.
內容註:	Basic theory of pharmacology for Alzheimer's disease -- Practical Pharmacology of Donepezil -- Practical pharmacology of Galantamine -- Practical pharmacology of Rivastigmine -- Practical Pharmacology of Memantine -- How do we use Symptomatic drugs for Dementia.
Contained By:	Springer eBooks
標題:	Alzheimer's disease. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-26206-2
ISBN:	9783319262062$q(electronic bk.)

Practical pharmacology for Alzheimer's disease
Practical pharmacology for Alzheimer's disease[electronic resource] /by Takashi Kudo ... [et al.]. - Cham :Springer International Publishing :2016. - viii, 141 p. :ill., digital ;24 cm.

Basic theory of pharmacology for Alzheimer's disease -- Practical Pharmacology of Donepezil -- Practical pharmacology of Galantamine -- Practical pharmacology of Rivastigmine -- Practical Pharmacology of Memantine -- How do we use Symptomatic drugs for Dementia.

The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer's disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. However, the fact that clinical trials of these drugs have not yet yielded satisfactory results has meant that for the time being patients continue to be treated only with symptomatic drugs. Currently, four such drugs are available: donepezil, galantamine, rivastigmine, and memantine. In this book, the four leading experts on each of these drugs explain their practical pharmacology with the aim of providing a sound basis for their use, which to date has been of questionable proficiency. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer's disease and the book closes with an overview of the ways in which symptomatic drugs are used for dementia.

ISBN: 9783319262062$q(electronic bk.)

Standard No.: 10.1007/978-3-319-26206-2doiSubjects--Topical Terms:

588010
Alzheimer's disease.

LC Class. No.: RC523

Dewey Class. No.: 616.831

Practical pharmacology for Alzheimer's disease
LDR:02083nmm a2200313 a 4500 001 2031019
003 DE-He213
005 20160822115934.0
006 m d
007 cr nn 008maaau
008 160908s2016 gw s 0 eng d
020 $a 9783319262062$q(electronic bk.)
020 $a 9783319262048$q(paper)
024 7 $a 10.1007/978-3-319-26206-2 $2 doi
035 $a 978-3-319-26206-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RC523
072 7 $a MMGW $2 bicssc
072 7 $a MED105020 $2 bisacsh
082 0 4 $a 616.831 $2 23
090 $a RC523 $b .P895 2016
245 0 0 $a Practical pharmacology for Alzheimer's disease $h [electronic resource] / $c by Takashi Kudo ... [et al.].
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a viii, 141 p. : $b ill., digital ; $c 24 cm.
505 0 $a Basic theory of pharmacology for Alzheimer's disease -- Practical Pharmacology of Donepezil -- Practical pharmacology of Galantamine -- Practical pharmacology of Rivastigmine -- Practical Pharmacology of Memantine -- How do we use Symptomatic drugs for Dementia.
520 $a The wide acceptance of the amyloid cascade hypothesis has led to vigorous development of disease-modifying drugs for Alzheimer's disease, such as amyloid vaccinations and gamma- or beta-secretase inhibitors. However, the fact that clinical trials of these drugs have not yet yielded satisfactory results has meant that for the time being patients continue to be treated only with symptomatic drugs. Currently, four such drugs are available: donepezil, galantamine, rivastigmine, and memantine. In this book, the four leading experts on each of these drugs explain their practical pharmacology with the aim of providing a sound basis for their use, which to date has been of questionable proficiency. In addition, an introductory chapter considers the basic theory of pharmacology for Alzheimer's disease and the book closes with an overview of the ways in which symptomatic drugs are used for dementia.
650 0 $a Alzheimer's disease. $3 588010
650 0 $a Alzheimer's disease $x Chemotherapy. $3 660091
650 0 $a Alzheimer's disease $x Treatment. $3 660535
650 0 $a Drugs $x Effectiveness. $3 2062994
650 1 4 $a Medicine & Public Health. $3 890906
650 2 4 $a Psychopharmacology. $3 568143
650 2 4 $a Neurology. $3 588698
650 2 4 $a Pharmacotherapy. $3 1978501
700 1 $a Kudo, Takashi. $3 2183144
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-26206-2
950 $a Medicine (Springer-11650)